Diacylglycerol O Acyltransferase 1 Market: Emerging Metabolic and...

Ajouter une nouvelle offre d'emploi Health

2026-08-10 07:51:46 -

Diacylglycerol O Acyltransferase 1 Market: Emerging Metabolic and Obesity Therapeutics

Market Overview The Diacylglycerol O Acyltransferase 1 (DGAT1) market is gaining momentum as biopharmaceutical researchers investigate novel enzymatic pathways to treat metabolic disorders, obesity, non-alcoholic fatty liver disease (NAFLD/MASH), and type 2 diabetes. DGAT1 is a key enzyme involved in the final, rate-limiting step of triglyceride synthesis, catalyzing the conversion of...

0 Commentaires 0 Parts 3 Vue 0 Aperçu